Pediatric-specific antimicrobial susceptibility data and empiric antibiotic selection

Pediatrics

Volumn 130, Issue 3, 2012, Pages

  Boggan, Joel C ^a   Navar Boggan, Ann Marie ^a   Jhaveri, Ravi ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antimicrobial resistance; Pediatric specific antimicrobial susceptibility; Quality of care

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFAZOLIN; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CASE STUDY; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DRUG CHOICE; DRUG EFFICACY; ESCHERICHIA COLI; FEMALE; HEALTH SURVEY; HUMAN; IN VITRO STUDY; INFANT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RESIDENT; STATISTICAL ANALYSIS; URINARY TRACT INFECTION;

EID: 84865750083     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2012-0563     Document Type: Article

References (18)

1. Cohen ML. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science. 1992;257(5073):1050-1055
2. Tenover FC, Hughes JM. The challenges of emerging infectious diseases. Development and spread of multiply-resistant bacterial pathogens. JAMA. 1996;275(4):300-304
3. Grenier C, Pépin J, Nault V, et al. Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia. J Antimicrob Chemother. 2011;66(7):1617-1624
4. Muszynski JA, Knatz NL, Sargel CL, Fernandez SA, Marquardt DJ, Hall MW. Timing of correct parenteral antibiotic initiation and outcomes from severe bacterial communityacquired pneumonia in children. Pediatr Infect Dis J. 2011;30(4):295-301
5. Goossens H, Ferech M, Vander Stichele R, Elseviers M; ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365(9459):579-587
6. Hsueh PR, Chen WH, Luh KT. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan. Int J Antimicrob Agents. 2005;26(6):463-472
7. Bertrand X, Dowzicky MJ. Antimicrobial susceptibility among gram-negative isolates collected from intensive care units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa between 2004 and 2009 as part of the Tigecycline Evaluation and Surveillance Trial. Clin Ther. 2012;34(1):124-137
8. Lubowski TJ, Woon JL, Hogan P, Hwang CC. Differences in antimicrobial susceptibility among hospitals in an integrated health system. Infect Control Hosp Epidemiol. 2001;22(6):379-382
9. Tonkic M, Goic-Barisic I, Punda-Polic V. Prevalence and antimicrobial resistance of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae strains isolated in a university hospital in Split, Croatia. Int Microbiol. 2005;8(2):119-124
10. Seppälä H, Klaukka T, Lehtonen R, Nenonen E, Huovinen P. Erythromycin resistance of group A streptococci from throat samples is related to age. Pediatr Infect Dis J. 1997;16(7):651-656
11. Blyth CC, Chen SC, Slavin MA, et al Australian Candidemia Study. Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. Pediatrics. 2009;123(5):1360-1368
12. David MZ, Crawford SE, Boyle-Vavra S, Hostetler MA, Kim DC, Daum RS. Contrasting pediatric and adult methicillin-resistant Staphylococcus aureus isolates. Emerg Infect Dis. 2006;12(4):631-637
13. Watt K, Waddle E, Jhaveri R. Changing epidemiology of serious bacterial infections in febrile infants without localizing signs. PLoS ONE. 2010;5(8):e12448
14. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE; Infectious Diseases Society of America (IDSA). Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis. 1999;29(4):745-758
15. Fridkin SK, Steward CD, Edwards JR, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis. 1999;29(2):245-252
16. Khanfar HS, Bindayna KM, Senok AC, Botta GA. Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings. J Infect Dev Ctries. 2009;3(4):295-299
17. Copp HL, Shapiro DJ, Hersh AL. National ambulatory antibiotic prescribing patterns for pediatric urinary tract infection, 1998-2007. Pediatrics. 2011;127(6):1027-1033
18. Zhang SX, Parisian F, Yau Y, Fuller JD, Poutanen SM, Richardson SE. Narrow-spectrum cephalosporin susceptibility testing of Escherichia coli with the BD Phoenix automated system: questionable utility of cephalothin as a predictor of cephalexin susceptibility. J Clin Microbiol. 2007;45(11):3762-3763